Apalutamide Now Also Approved for Metastatic Prostate Cancer Apalutamide Now Also Approved for Metastatic Prostate Cancer

The androgen receptor inhibitor, which is already approved for use in nonmetastatic castration-resistant prostate cancer, has now been approved for a different patient population.FDA Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news